Colon Cancer Research
More than 40 percent of us will develop cancer and more than 20 percent of us will die from it. NorthShore University HealthSystem investigators continue making inroads to identify cancers at the earliest stages and to prevent cancer in those found to be genetically susceptible. With more than 180,000 new cases each year, breast cancer is the most common cancer afflicting American women. Prostate cancer is now the most common cancer in men. Colorectal cancer also ranks among the most prevalent malignancies and, fortunately, is one of the most well studied.
NorthShore has taken the lead on pioneering a dynamic new technology which if successful will differentiate normal cells from early pre-malignant cells with the use of light.
Pancreatic Cancer Research
Pancreatic cancer is currently the fourth leading cause of cancer death in both males and females. It is estimated that adenocarcinomas of the pancreas will be the cause of nearly 30,000 deaths in the United States this year. Prognosis is extremely poor with less than a 5% survival rate over a five year period. NorthShore investigators are determined to find ways to assist with the survival rate of persons with cancers of the pancreas. They hope that the results of their research will lead to earlier diagnosis and detection, identification of novel genes to improve patient outcome and to find ways to prevent this type of cancer especially in those with a familial history of pancreatic cancer.
Visit the Kellogg Cancer Center for more information about gastrointestinal cancers.